Calming Canines: How Science-Backed Ashwagandha is Redefining Pet Wellness

LOS ANGELES, CA – March 06, 2026 – As pet owners increasingly seek solutions for their anxious companions, the line between human and animal wellness is blurring. A new partnership between Ixoreal Biomed, the maker of the clinically studied KSM-66 Ashwagandha, and science-focused pet wellness brand Boops Pets is set to make waves in the booming pet supplement market. Boops Pets will feature the patented adaptogenic herb in its new Calming & Stress Relief supplement for dogs, signaling a significant shift towards evidence-based, human-grade ingredients in pet care.

The collaboration comes at a critical time. Fear, stress, and anxiety are becoming more prevalent in domestic dogs, driven by factors ranging from post-pandemic separation anxiety to the overstimulation of urban environments. This has fueled unprecedented demand for calming aids, with the global pet calming supplement market projected to nearly double from $952.4 million in 2024 to a staggering $1.7 billion by 2032. In this rapidly growing and often confusing market, a new premium is being placed on scientific validation—a standard this partnership aims to embody.

The Rise of Evidence-Based Pet Wellness

The modern pet owner is no longer just a caregiver; they are a wellness advocate. This trend, often termed "pet humanization," has led to a dramatic shift in consumer behavior. Owners now scrutinize ingredient labels, demand transparency, and seek the same quality and efficacy for their pets' products as they do for their own. This has created a demand for supplements that are not only natural but are also backed by rigorous scientific data.

Boops Pets has built its brand on this very principle. As a company audited by the National Animal Supplement Council (NASC), it adheres to strict quality control and manufacturing standards. The NASC Quality Seal is a hard-earned badge of honor in the industry, signifying a commitment to safety, purity, and transparency. It was this commitment that drove their search for an ideal calming ingredient.

"We approach our supply chain with a zero-compromise policy on traceability and data," says Jeffrey Meng, founder of Boops Pets. This philosophy led them away from generic ingredients and towards a partner with verifiable credentials. "After auditing multiple ashwagandha sources, we found KSM-66 Ashwagandha was the only one that offered the batch-to-batch consistency and validated clinical evidence specifically for dogs."

Meng also highlighted a crucial factor that sets Ixoreal Biomed apart: its investment in animal-specific research. "Meng also cited KSM-66 Ashwagandha's commitment to fund peer-reviewed animal-specific studies on the herb, which demonstrates a level of responsibility that is rare in the supply chain."

Not All Ashwagandha Is Created Equal

Ashwagandha, an ancient herb from Ayurvedic medicine, is well-known in human wellness circles for its adaptogenic properties—helping the body manage and adapt to stress. However, its application in veterinary science required a higher standard of proof. KSM-66 Ashwagandha stands out as the most researched and clinically tested version of the herb available for pets, boasting an impressive 46 certifications for safety and efficacy.

Unlike many supplements that rely on anecdotal evidence, KSM-66's benefits for dogs are documented in gold-standard clinical trials. A key peer-reviewed study published in the Journal of Veterinary Behavior found that dogs supplemented with KSM-66 showed a significant reduction in their urine cortisol-to-creatinine ratio—a key biomarker for stress. The study also documented marked improvements in behavioral signs of fear and anxiety, all without adverse side effects.

"We've long known that ashwagandha can help humans manage stress, and research shows it can be equally effective for pets," explains Kartikeya Baldwa, CEO of Ixoreal Biomed. "We believe all animals can benefit from KSM-66 Ashwagandha's safe and natural calming powers, and we're thrilled to partner with Boops Pets, a company dedicated to quality, scientific rigor, and proven pet health supplements that support lifelong wellness."

The efficacy of KSM-66 lies in its high concentration of active compounds, known as withanolides, which are derived exclusively from the root of the plant using a proprietary, chemical-free extraction process. This method ensures a pure, potent, and neutral-tasting product that doesn't affect the palatability of the final supplement—a crucial factor for picky eaters.

Navigating a Crowded Calming Market

The pet calming market is a crowded field, with products featuring a wide array of ingredients, including L-Theanine, chamomile, melatonin, valerian root, and the increasingly popular CBD. While many of these have a reputation for promoting calmness, the level of direct, canine-specific clinical research can vary widely. This is where the Boops Pets and KSM-66 partnership seeks to carve out its niche.

By focusing on a single, heavily researched ingredient, the new supplement offers a targeted approach grounded in veterinary science. Rather than relying on a cocktail of botanicals, the formulation centers on the proven mechanism of KSM-66: supporting the hypothalamic-pituitary-adrenal (HPA) axis. This system regulates the body's stress response, including the production of the primary stress hormone, cortisol. By helping to maintain healthy cortisol levels, the adaptogen promotes a state of balance and resilience, allowing dogs to better cope with stressors like travel, loud noises, or time alone.

This evidence-based approach provides a clear point of differentiation for discerning pet owners and veterinarians who are navigating a marketplace filled with competing claims. The combination of a NASC-audited brand and an ingredient with published, placebo-controlled trials in dogs creates a new benchmark for what consumers can and should expect from a pet wellness product.

As the bond between humans and their pets continues to deepen, the demand for products that enhance animal well-being will only grow. The collaboration between Boops Pets and Ixoreal Biomed is more than just the launch of a new supplement; it represents the maturation of the pet wellness industry, where rigorous science is finally catching up to the unconditional love we have for our canine companions.